Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

MYCOBACTERIUM - ANVISA Registration 10338930301

Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10338930301 and manufactured by OXFORD IMMUNOTEC LTD. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Sep 17, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10338930301
2 Related Devices
Registration Details
ANVISA Registration Number: 10338930301
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

T-SPOT® TB
Risk Class III

Registration Details

10338930301

25351799577202318

93741726000166

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

Dec 18, 2023

17/09/2028

09/18/2025 19:00:01

T-SPOT® TB
Risk Class III

Registration Details

10338930301

25351799577202318

93741726000166

Company Information

Dates and Status

Dec 18, 2023

17/09/2028

09/18/2025 19:00:01